News
From our correspondent Perry Lesion...| Trends in Wound Care vol V |
|
The fifth volume in this popular series of Trends in Wound Care is edited by Keith F Cutting and is now available from Quay Books. The Foreword written by Prof R White (University of Worcester) includes the statement - This highly reputable source of up-to-date monographs has become a standard text for those seeking to keep in touch with key areas of clinical and scientific research. Copies may be ordered via the Quay Books website at Trends V. Happy Reading.
Mon 23 Mar 2009 by Perry Lesion |
| Unomedical head towards Aspen |
|
ConvaTec has announced the divestiture of Unomedical wound care to Aspen Surgical Products Holding, Inc. Aspen are in turn owned by private equity firm RoundTable Healthcare Partners. If you want to read more take a look at ConvaTec divests.
Sun 01 Mar 2009 by Perry Lesion |
| Smith and Nephew and NPWT - new device |
|
First of all it was Blue Sky that morphed into Vista and now we have RENASYS EZ. Smith and Nephew have launched a new NPWT device at American Academy of Orthopaedic Surgeons Annual Meeting in Las Vegas. You can read more at RENASYS EZ
Wed 25 Feb 2009 by Perry Lesion |
| Baby boomers assist Smith and Nephew |
|
Smith and Nephew appear to be benefiting from the aging joints of Baby Boomers and this has combined with a strong demand for wound management products. Read it all at Ride the recession.
Sun 15 Feb 2009 by Perry Lesion |
| KCI patents upheld |
|
Two key patents have been upheld by a federal court. The market reacted favorably to this news even though the 2006 court decision partially in favor of competitor Blue Sky was not overturned. Read more at Blue Skies for KCI.
Wed 04 Feb 2009 by Perry Lesion |
| KCI profits down |
|
KCI report a 21.7 percent drop in profit from 12 months ago. This is blamed on restructuring costs and the acquisition of LifeCell. None the less revenue was up 14 percent to $492.5 million. Read the full story at KCI profit drop. Wed 28 Jan 2009 by Perry Lesion |
| The good news and the bad news |
|
ConvaTec have announced signing of a long-term global agreement with Boehringer Technologies to market and distribute Boehringer's Engenex(R) Negative Pressure Wound Therapy System. The press release may be viewed at ConvaTec and Boehringer. It seems that KCI do not like another threat looming on the NPWT horizon and have filed a patent infringement suit against ConvaTec and Boehringer. C'est la vie, c'est la guerre
Fri 19 Dec 2008 by Perry Lesion |
| The end of an era! |
|
The sale of J and J wound care division ETHICON has been completed. The new owners One Equity Partners are now in the driving seat. Read on...One Equity Partners
Tue 02 Dec 2008 by Perry Lesion |
| New study on Quick-Med's NIMBUS(R) Technology - No Threat of Bacterial Resistance |
|
Quick-Med have presented conclusive evidence at Symposium on Skin and Wound Care that their NIMBUS(R) antimicrobial technology poses no threat of bacterial resistance. This must be welcome news in days of frequent reports of serious infections from exposure to MRSA and VRE. Read more at No Threat
Wed 19 Nov 2008 by Perry Lesion |
| Are Best Practice statements in wound care of value |
|
A recent opinion piece in Journal of Wound Care questions the value of Best Practice statements. The authors K Cutting and R White suggest that we should take a look at their provenance before blindly adopting them. The reference is Cutting KF, White RJ 2008. Quality assurance that will ensure robust and transparent guidelines. Journal of Wound Care 17,10:451. Tue 18 Nov 2008 by Perry Lesion |